EDGAR Filing Documents for 0001144204-17-016300

Form 8-K - Current report:

SEC Accession No. 0001144204-17-016300

Filing Date

2017-03-23

Accepted

2017-03-23 17:00:57

Documents

Period of Report

2017-03-17

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v462081_8k.htm	8-K	22292
2	EXHIBIT 10.1	v462081_ex10-1.htm	EX-10.1	206866
3	EXHIBIT 10.2	v462081_ex10-2.htm	EX-10.2	88784
4	EXHIBIT 10.3	v462081_ex10-3.htm	EX-10.3	88799
5	EXHIBIT 10.4	v462081_ex10-4.htm	EX-10.4	88725
6	EXHIBIT 10.5	v462081_ex10-5.htm	EX-10.5	79592
7	EXHIBIT 99.1	v462081_ex99-1.htm	EX-99.1	11532
8	GRAPHIC	image_001.jpg	GRAPHIC	4544
9	GRAPHIC	image_002.jpg	GRAPHIC	17010
	Complete submission text file	0001144204-17-016300.txt		617694

Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814

Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024

NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)